Mizuho analyst Ann Hynes reiterates this morning that her model suggests Acadia Healthcare's (ACHC) maximum leveraged buyout take-out price is $48.00 per share given its current debt levels. The stock in premarket trading is up 8%, or $3.32, to $39.00 after Reuters reported that the company is in talks with private equity firms about selling itself after attracting buyout interest. KKR (KKR) and TPG Global are among the private equity firms that have approached Acadia, according to Reuters. Hynes keeps a Neutral rating on Acadia shares with a $37 price target.